Emerging cytoprotective peptide therapies for stroke
Expert Rev Neurother
.
2020 Sep;20(9):887-890.
doi: 10.1080/14737175.2020.1788390.
Epub 2020 Aug 19.
Authors
Bruno P Meloni
1
2
3
,
David J Blacker
1
2
4
,
Frank L Mastaglia
1
2
,
Neville W Knuckey
1
2
3
Affiliations
1
Perron Institute for Neurological and Translational Science , Nedlands, Australia.
2
Department of Neurosurgery, Sir Charles Gairdner Hospital, QEII Medical Centre , Nedlands, Western Australia, Australia.
3
Centre for Neuromuscular and Neurological Disorders, The University of Western Australia , Nedlands, Western Australia, Australia.
4
Department of Neurology, Sir Charles Gairdner Hospital, QEII Medical Centre , Nedlands, Western Australia, Australia.
PMID:
32580598
DOI:
10.1080/14737175.2020.1788390
No abstract available
Keywords:
CN-105; NA-1; R18; Stroke; cationic arginine-rich peptides (CARPs); neuroprotection.
Publication types
Editorial